Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LifeStem dendritic cell vaccine
- Development stage
- Preclinical
- Lead developer
- LifeStem
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Administration
- Injection
01
Overview
LifeStem's dendritic cell-based tumor vaccine is an autologous cell therapy under development for the treatment of malignant glioma. This cancer immunotherapy involves the extraction of a patient's own dendritic cells, which are then primed or loaded with tumor-specific antigens. Once re-administered to the patient, these activated dendritic cells act as professional antigen-presenting cells, stimulating a targeted T-cell-mediated immune response against the glioma cells. The goal of this vaccine is to harness the patient's immune system to recognize and eliminate malignant cells while potentially establishing long-term immunological memory to prevent recurrence.
- Other names
- dendritic cell-based tumor vaccinedendritic cell vaccineLifeStem dendritic cell therapycancer immunotherapy-Malignant Glioma
Beyond the preview
Go deeper on LifeStem dendritic cell vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LifeStem dendritic cell vaccine.